MoneyWorks4Me

Ajanta Pharma informs about company updates

10 Apr 2017 Evaluate

Ajanta Pharma has informed that the Company’s formulation facility at Dahej was inspected by US FDA from 3rd to 7th April, 2017. At the end of the inspection, no Form 483 was issued to the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..